Log In
Print
BCIQ
Print
Print this Print this
 

C. difficile vaccine (IC84)

Also known as: IC48

  Manage Alerts
Collapse Summary General Information
Company Valneva SE
DescriptionRecombinant protein vaccine consisting of 2 truncated toxins A and B from Clostridium difficile
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationClostridium
Indication DetailsVaccinate against C. difficile infection
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today